| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| 2'-deoxy-2'-fluoro-2'-C-methyluridine |
(2'R)-2'-脫氧-2'-氟-2'-甲基脲苷 |
863329-66-2 |
詳細(xì)
|
| Cytidine, N-benzoyl-2'-deoxy-2'-fluoro-2'-methyl-, 3',5'-dibenzoate,(2'R)- |
(2'R)-N-苯甲?；?2'-脫氧-2'-氟-2'-甲基胞苷 3',5'-二苯甲酸酯 |
817204-32-3 |
詳細(xì)
|
| Ledipasvir (acetone) |
雷迪帕韋單丙酮溶劑化物 |
1441674-54-9 |
詳細(xì)
|
| PSI 7977 |
索非布韋 |
1190307-88-0 |
詳細(xì)
|
| Velpatasvir |
維帕他韋 |
1377049-84-7 |
詳細(xì)
|
| Velpatasvir intermediate;tert-butyl(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(methoxycarbonyl)-L-valyl]-5-methylpyrrolidin-2-yl}-1,11-dihydroisochromeno[4′,3′:6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate |
2S,4S)-2-[5-[1,11-二氫-2-[(2S,5S)-1-[(2S)-2-[(甲氧羰基)氨基]-3-甲基-1-氧代丁基]-5-甲基-2-吡咯烷基][2]苯并吡喃并[4',3':6,7]萘并[1,2-D]咪唑-9-基]-1H-咪唑-2-基]-4-(甲氧基甲基)-1-吡咯烷羧酸叔丁酯;GS-5816 N-3中間體;叔丁基(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(甲氧基羰基)-L-纈氨酰]-5-甲基吡咯烷-2-基}-1,11-二氫異吡喃[4′,3′:6,7]萘并[1,2-D]咪唑-9-基)-1H-咪唑-2-基] -4-(甲氧基甲基)吡咯烷-1-羧酸 |
1378391-45-7 |
詳細(xì)
|
| Velpatasvir intermediate;tert-butyl(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(methoxycarbonyl)-L-valyl]-5-methylpyrrolidin-2-yl}-1,4,5,11-tetrahydroisochromeno[4′,3′:6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate |
維帕他韋中間體；叔丁基 (2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(甲氧基羰基)-L-纈氨酰]-5-甲基吡咯烷-2-基}-1,4,5,11-四氫異吡喃[4′,3′:6,7]萘并[1,2-D]咪唑-9-基)-1H-咪唑-2-基]-4-(甲氧基甲基)吡咯烷-1-羧酸 |
1378391-44-6 |
詳細(xì)
|
| Velpatasvir intermediate;VP N-3;
(2R,4R)-1-tert-butyl2-(2-(9-((2S,5S)-1-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carbonyloxy)-8-oxo-8,9,10,11-tetrahydro-5H-dibenzo[c,g]chromen-3-yl)-2-oxoethyl) 4-(methoxymethyl)pyrrolidine-1,2-dicarboxylate |
維帕他韋中間體VP N-3;(2R,4R)-1-叔丁基2-(2-(9-((2S,5S)-1-((S)-2-(甲氧基羰基氨基)-3-甲基丁?；?-5-甲基吡咯烷-2-羰氧基)-8-氧代-8,9,10,11-四氫-5H-二苯并[C,G]吡喃-3-基)2-氧代乙基)-4-(甲氧基甲基)吡咯烷-1,2-二羧酸 |
1378391-43-5 |
詳細(xì)
|
| (2S,4S)-1-(tert-butoxycarbonyl)-4-(MethoxyMethyl)pyrrolidine-2-carboxylic acid;(2S,4S)-1-(tert-butoxycarbonyl)-4-(MethoxyMethyl)pyrrolidine-2-carboxylic acid;(2S,4S)-4-(Methoxymethyl)-1,2-pyrrolidinedicarboxylicacid1-(1,1-dimethylethyl)ester;GS-5816interMediate;3-(2-bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one |
(2S,4S)-1-(叔丁氧羰基)-4-(甲氧甲基)吡咯啉-2-羧酸；(2S,4S)-1-(叔丁氧羰基)-4-(甲氧甲基)吡咯啉-2-羧酸;(2S,4S)-4-(甲氧基甲基)-1,2-吡咯烷二甲酸 1-叔丁基酯;GS-5816中間體;5816中間體,SM2 |
1378388-16-9 |
詳細(xì)
|
| (5S)-N-(Methoxycarbonyl)-L-valyl-5-methyl-L-proline;(2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid;(2S,4S)-1-((R)-2-((methoxycarbonyl)amino)-2-phenylacetyl)-4-(methoxymethyl)pyrrolidine-2-carboxylicacid;(5S)-N-(Methoxycarbonyl)-L-valyl-5-methyl-L-proline;(2S,5S)-1-((S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carboxylic acid |
(5S)-N-(甲氧羰基)-L-纈氨酰-5-甲基-L-脯氨酸；VELPATASVIR 中間體;(5S)-N-(甲氧羰基)-L-纈氨酰-5-甲基-L-脯氨酸 |
1335316-40-9 |
詳細(xì)
|
| 9-Bromo-3-(2-Bromo Acetyl)-10,11-Dihydro-5H-dibenzo(c,g) Chromen-8(9H)-one |
9-溴-3-(2-溴乙?；?-10,11-二氫-5H-二苯并(C,G) CHROMEN-8(9H)-酮 |
1438383-89-1 |
詳細(xì)
|
| Chenodeoxycholic acid;URSODEOXYCHOLOCACID;3,7-dihydroxy-,(3-alpha,5-beta,7-alpha)-cholan-24-oicaci;3,7-dihydroxy-,(3alpha,5beta,7alpha)-cholan-24-oicaci;3,7-Dihydroxy-5-Cholanicacid;3-alpha,7-alpha-dihydroxy-5-beta-cholan-24-oicaci;3-alpha,7-alpha-dihydroxy-5-beta-cholan-24-oicacid;3-alpha,7-alpha-dihydroxycholanicacid;3-alpha,7-alpha-dihydroxycholansaeure |
鵝去氧膽酸；鵝脫氧膽酸;脫氧鵝膽酸;脫氧脲苷;3alpha,7alpha-二羥基-5beta-膽烷酸;3α,7α-二羥基-5-β-膽烷酸;3α,7α-二羥基膽質(zhì)酸;護(hù)肝素 |
474-25-9 |
詳細(xì)
|
| Dolutegravi;GSK1349572;(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide;S/GSK1349572(GSK1349572);Dolutegravir;GSK1349572(dolutegravir);S/GSK1349572;dolutegravir/GSK1349572/S-349572;Dolutegravir API |
杜魯特韋；(4R,12AS)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12A-六氫-7-羥基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3]嗪-9-甲酰胺;度魯特韋;德羅特韋;4R,12AS)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12A-六氫-7-羥基-4-甲基-6,8-二氧代-2H-吡啶并[1;DOLUTEGRAVIR 度魯特韋;德羅特韋 GSK1349572;德羅特韋(GSK-1349572,DTG); |
1051375-16-6 |
詳細(xì)
|
| GSK1349572sodiuMsalt;DOLUTEGRAVIRSODIUM;GSK1349572A;Dolutegravir sodiuM salt;Dolutegravir SodiuM ( API) |
度魯特韋鈉鹽；度魯特韋鈉 |
1051375-19-9 |
詳細(xì)
|
| Mirabegron;YM 178;Mirabegron;MIRABEQRON;Mirabegron, >=99%;Mirabegron(YM 178);Merariveron impurity B;N-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)-2-(2-aminothiazol-4-yl)acetamide;2-AMino-N-[4-[2-[[(2R)-2-hydroxy-2-phenyl-ethyl]aMino]-ethyl]phenyl]-4-thiazoleacetaMide;4-Thiazoleacetamide, 2-amino-N-(4-(2-(((2R)-2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)-;2-(2-aMino-1,3-thiazol-4-yl)-N-(4-{2-[(2-hydroxy-2-phenylethyl)aMino]ethyl}phenyl)acetaMide |
米拉貝?。幻桌惵?米拉貝隆API;米拉貝隆雜質(zhì)B;2-氨基-N-[4-[2-[[(2R)-2-羥基-2-苯基乙基]氨基]乙基]苯基]-4-噻唑乙酰胺;(R)-2-(2-氨基噻唑-4-基)-4'-[2-[(2-羥基-2-苯基乙基) 氨基]乙基]乙酸?；桨?/td>
| 223673-61-8 |
詳細(xì)
|
| N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride;BMS790052;N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic aciddimethylesterhydrochloride;BMS-790052(dihydrochloride);BMS790052HCl;Daclatasvirdihydrochloride;DACLATASVIR(2HCl);Daclatasvir HCL |
達(dá)卡他韋二鹽酸鹽；N,N'-[[1,1'-聯(lián)苯]-4,4'-二基雙[1H-咪唑-5,2-二基-(2S)-2,1-吡咯烷二基[(1S)-1-(1-甲基乙基)-2-氧代-2,1-乙烷二基]]]二氨基甲酸二甲酯二鹽酸鹽;吡咯烷二基[(1S)-1-(1-甲基乙基)-2-氧代-2,1-乙烷二基]]]二氨基甲酸二甲酯二鹽酸鹽;達(dá)卡他韋雙鹽酸鹽;達(dá)卡他韋二鹽酸鹽;鹽酸達(dá)卡他韋;達(dá)卡他韋,達(dá)卡他韋二鹽酸鹽;達(dá)卡他韋鹽 |
1009119-65-6 |
詳細(xì)
|
| Obeticholic Acid;6-Ethylchenodeoxycholicacid;6alpha-Ethyl-chenodeoxycholicacid;6-Ecdca;6-Ethyl-cdca;C15636;6-Ethylchenodeoxycholicacid(ObeticholicAcid);Obeticholic Acid;(3α,5β,6α,7α)-6-ethyl-3,7-dihydroxy-cholan-24-oic acid |
奧貝膽酸；6-乙基鵝去氧膽酸;奧貝膽酸;奧貝膽酸 (6-乙基鵝去氧膽酸);奧貝膽酸 459789-99-2 ECDC |
459789-99-2 |
詳細(xì)
|
| Daclatasvir;dimethyl(2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate;diMethyl(2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl);Daclatasvir;EBP883;N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acidC,C'-dimethylester;Daclatasvir/EBP883;daclatavir;BMS-790052(Daclatasvir) |
達(dá)卡他韋；N,N'-[[1,1'-聯(lián)苯]-4,4'-二基雙[1H-咪唑-5,2-二基-(2S)-2,1-吡咯烷二基 [(1S)-1-(1-甲基乙基)-2-氧代-2,1-乙烷二基]]]雙氨基甲酸 C,C'-二甲酯;DACLATASVIR (BMS-790052) N,N'-[[1,1'-聯(lián)苯]-4,4'-二基雙[1H-咪唑-5,2-二基-(2S)-2,1-吡咯烷二基 [(1S)-1-(1-甲基乙基)-2-氧代-2,1-乙烷二基]]]雙氨基甲酸 C,C'-二甲酯; |
1009119-64-5 |
詳細(xì)
|
| (1R,3S,4S)-3-(6-Bromo-1H-benzimidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester |
(1R,3S,4S)-3-(6-溴-1H-苯并咪唑-2-基)-2-氮雜雙環(huán)[2.2.1]庚烷-2-羧酸叔丁酯 |
1256387-74-2 |
詳細(xì)
|
| (1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester |
(1R,3S,4S)-3-[6-(4,4,5,5-四甲基-1,3,2-二氧雜環(huán)戊硼烷-2-基)-1H-苯并咪唑-2-基]-2-氮雜雙環(huán)[2.2.1]庚烷-2-羧酸叔丁酯 |
1256387-87-7 |
詳細(xì)
|
| (1R,3S,4S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid |
(1R,3S,4S)-N-叔丁氧羰基-2-氮雜雙環(huán)[2.2.1]庚烷-3-羧酸 |
291775-59-2 |
詳細(xì)
|
| (6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester |
(6S)-5-叔丁氧羰基-6-(5-(7-溴-9,9-二氟-9H-芴-2-基)-1H-咪唑-2-基)-5-氮雜螺-[2.4]-庚烷 |
1441670-89-8 |
詳細(xì)
|
| (S)-5-(tert-Butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid |
(6S)-5-叔丁氧羰基-5-氮雜螺-[2.4]-庚烷-6-羧酸 |
129634-44-1 |
詳細(xì)
|
| 1-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-2-chloroethanone |
1-(7-溴-9,9-二氟-9H-芴-2-基)-2-氯乙酮 |
1378387-81-5 |
詳細(xì)
|
| N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester |
N-[(S)-(2,3,4,5,6-五氟苯氧基)苯氧基磷?；鵠-L-丙氨酸異丙酯 |
1334513-02-8 |
詳細(xì)
|